The partial virological response to Tenofovir monotherapy in naive patients with chronic hepatitis B

被引：0
|
作者：
Gedik, Habip [1 ,2 ]
Sonmezisik, Muge [1 ,2 ]
机构：
[1] Univ Hlth Sci, Dept Infect Dis & Clin Microbiol, Istanbul, Turkey
[2] Minist Hlth, Bakirkoy Dr Sadi Konuk Training & Res Hosp, Istanbul, Turkey
来源：
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION | 2021年 / 71卷 / 02期
关键词：
Chronic hepatitis B; Tenofovir; partial response; Entecavir; combination therapy; DISOPROXIL FUMARATE; SAFETY;
D O I：
10.47391/JPMA.1135
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We report two treatment-na?ve cases, a 26-year-old female patient and a 59-year-old male patient who were followed up for chronic hepatitis B (CHB) at the department of Infectious Diseases and Clinical microbiology. A partial response subsequent to 12 months of Tenofovir Disoproksil (TDF) monotherapy presumably due to an antiviral-drug resistance was noted. A sustained viral response with TDF (245 mg) or Tenofovir Alafenamide (TAF, 25 mg) + Entecavir (ETV, 1 mg) combination therapy was observed after failure with TDF monotherapy. A combination therapy with TDF (245 mg) or TAF (25 mg) +ETV (1 mg) is efficacious in na?ve patients with a partial response to TDF monotherapy.
引用
收藏
页码：550 / 552
页数：3
相关论文
共 50 条
  • [31] TENOFOVIR MONOTHERAPY FOR NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A MULTICENTER EUROPEAN STUDY IN CLINICAL PRACTICE IN 302 PATIENTS FOLLOWED FOR 30 MONTHS
    Lampertico, P.
    Soffredini, R.
    Vigano, M.
    Yurdaydin, C.
    Idilman, R.
    Papatheodoridis, G.
    Ekaterini, M.
    Buti, M.
    Esteban, R.
    Zaltron, S.
    Vavassori, A.
    Carosi, G.
    Minola, E.
    Vinci, M.
    Pinzello, G.
    Giorgini, A.
    Zuin, M.
    Salmi, A.
    Del Poggio, P.
    De Filippi, F.
    Bruno, S.
    Pasulo, L.
    Fagiuoli, S.
    Andreoletti, M.
    Colli, A.
    Maldini, F. Fumagalli
    Milanese, M.
    Colombo, A. E.
    Bellati, G.
    Angeli, E.
    Magni, C.
    Gubertini, G.
    Rizzardini, G.
    Fasano, M.
    Santantonio, T.
    Terreni, N.
    Spinzi, G.
    Facchetti, F.
    Invernizzi, F.
    Colombo, M.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S208 - S208
  • [32] Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naive patients with chronic hepatitis B
    Seo, Hee Yeon
    Lee, Han Ah
    Ko, Soon Young
    Wang, Joon Ho
    Kim, Jeong Han
    Choe, Won Hyeok
    Kwon, So Young
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2017, 23 (02) : 154 - 159
  • [33] Efficacy of Combination Tenofovir Plus Lamivudine Versus Tenofovir Monotherapy in Patients With Chronic Hepatitis B Virus
    Glyn, Frederick J.
    Gill, Upkar
    Alazawi, William
    Ross, Valerie
    Kooner, Paul
    Marley, Richard
    Foster, Graham
    Kennedy, Patrick T.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S455 - S455
  • [34] EFFICACY OF COMBINATION TENOFOVIR PLUS LAMIVUDINE VERSUS TENOFOVIR MONOTHERAPY IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS
    Glyn, F.
    Gill, U. S.
    Alazawi, W.
    Ross, V.
    Kooner, P.
    Marley, R.
    Foster, G. R.
    Kennedy, P. T. F.
    [J]. GUT, 2011, 60 : A231 - A231
  • [35] Entecavir treatment for chronic hepatitis B: Adaptation is not needed for the majority of naive patients with a partial virological response (vol 201, pg 443, 2011)
    Zoutendijk, R.
    [J]. HEPATOLOGY, 2011, 54 (06) : 2280 - 2281
  • [36] Baseline predictors of virological response for chronic hepatitis B patients
    Xue-Jie Wu
    [J]. World Journal of Gastroenterology, 2009, 15 (34) : 4311 - 4315
  • [37] Baseline predictors of virological response for chronic hepatitis B patients
    Wu, Xue-Jie
    Wang, Yan
    Chen, Ji
    Wang, Gui-Qiang
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (34) : 4311 - 4315
  • [38] Rely to: 'Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatment: Methodological issues'
    Tao, Ya-Chao
    Chen, En-Qiang
    [J]. JOURNAL OF VIRAL HEPATITIS, 2021, 28 (01) : 221 - 222
  • [39] Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B
    Ishido, Shun
    Tamaki, Nobuharu
    Uchihara, Naoki
    Suzuki, Keito
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Matsumoto, Hiroaki
    Nobusawa, Tsubasa
    Keitoku, Taisei
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Takahashi, Yuka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Itakura, Jun
    Kurosaki, Masayuki
    Izumi, Namiki
    [J]. JGH OPEN, 2023, 7 (08): : 567 - 571
  • [40] Does Hepatic Steatosis Influence the Virological Response with Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir Disoproxil Fumarate?
    Atalay, Roni
    Sayar, Suleyman
    Ayranci, Fatma Gulcicek
    Cakmak, Suheda
    Tanboga, Ibrahim Halil
    Doganay, Levent
    Ozdil, Kamil
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (07): : 587 - 595
12345